Post
Carolyn Bertozzi @CarolynBertozzi · Nov 16, 2022
  • From Twitter

Nice summary of ⁦@michal_stanczak⁩ and ⁦@LImmunotherapy⁩’s recent publication in ⁦@ScienceTM⁩ on Siglec/sialoglycan axis as target for cancer immune therapy, with the ⁦@Palleon_Pharma⁩ team and us as collaborators. #glycotime

Recommended by 1 person
1 mention
Share on Twitter Repost
Replies
Reply
No replies yet